微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Streptococcus agalactiae Lehmann and Neumann |
|---|---|
| 商品货号： | TS132975 |
| Strain Designations： | PF549AR-B |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Preparation of antisera for detection of pathogenic Group B streptococci |
| Medium： | ATCC® Medium 44: Brain Heart Infusion Agar/Broth ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Aerobic |
| Name of Depositor： | University of Florida, Gainesville |
| U.S. Patent Number： | |
| References： | Boyle MD, Brady LJ. Novel bacterial markers for pathogenic group B streptococci. US Patent 5,098,827 dated Mar 24 1992 Boyle MD, Brady LJ. Antigen of group B streptococci. US Patent 5,472,696 dated Dec 5 1995 |